Medical Devices Europe

Europe Molecular Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Europe Molecular Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Technology, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $5.93 Bn Placeholder estimate
Estimate 2025 $6.45 Bn 21.3% of the global market
Projected 2034 $13.78 Bn 113.6% Adds $7.33 Bn over 9 forecast years
CAGR 2025–2034 8.8% Faster than 62% of 193 Medical Devices markets here
Key players 6 +1
  • Europe is 21.33% of the global market.
  • Among regions, the largest is North America at $16.35 Bn.
  • Fastest growing: Middle East at 11.3% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$7.33 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Molecular Diagnostics Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $5.93 Bn — —
2025 (base) $6.45 Bn +$521.9 Mn —
2026 (forecast) $7.02 Bn +$567.8 Mn +8.8%
2027 (forecast) $7.64 Bn +$617.8 Mn +18.4%
2028 (forecast) $8.31 Bn +$672.2 Mn +28.8%
2029 (forecast) $9.04 Bn +$731.3 Mn +40.1%
2030 (forecast) $9.84 Bn +$795.7 Mn +52.5%
2031 (forecast) $10.70 Bn +$865.7 Mn +65.9%
2032 (forecast) $11.65 Bn +$941.9 Mn +80.5%
2033 (forecast) $12.67 Bn +$1.02 Bn +96.4%
2034 (forecast) $13.78 Bn +$1.11 Bn +113.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Molecular Diagnostics Market Analysis at a glance
Market size, 2025$6.45 Bn placeholder estimate
Forecast, 2034$13.78 Bn placeholder estimate
Growth (CAGR), 2025–20348.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, application and end user (see all)
Key playersRoche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and 1 more (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Molecular Diagnostics Market Analysis Executive Summary

Molecular diagnostics tests read DNA, RNA and proteins to find infections, cancer and inherited disease.

Key segments of the molecular diagnostics market include technology (PCR, Sequencing and Isothermal Amplification) and application (Infectious Disease, Oncology and Genetic Disease).

Bar chart: Europe Molecular Diagnostics market size, 2024–2034, placeholder estimates. $5.93 Bn in 2024, $6.45 Bn in 2025 and $13.78 Bn in 2034, 8.8% CAGR.
Europe Molecular Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Molecular Diagnostics Market Dynamics

Market Growth Drivers

Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.

Opportunity

Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the molecular diagnostics market room to grow.

Market Restraints

Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the molecular diagnostics market.

Competitive Landscape for Molecular Diagnostics Market in Europe

The molecular diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Molecular Diagnostics Market in Europe

Molecular Diagnostics in Europe: rules and payment

In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.⁠[1] In the countries we cover here, medical devices are regulated by ANSM (France)⁠[2], BfArM (Germany)⁠[3], Ministry of Health (Italy)⁠[4], Roszdravnadzor (Russia)⁠[5], AEMPS (Spain)⁠[6], MHRA (UK)⁠[7], IGJ (Netherlands)⁠[8], FAMHP (Belgium)⁠[9], Swissmedic (Switzerland)⁠[10], Läkemedelsverket (Sweden)⁠[11], Danish Medicines Agency (Denmark)⁠[12], URPL (Poland)⁠[13] and TITCK (Turkey)⁠[14]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[15]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how molecular diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.

Public data, with sources

Molecular Diagnostics in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Molecular Diagnostics market in Europe?
Placeholder estimate: about $6.45 Bn in 2025, rising to about $13.78 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Molecular Diagnostics market in Europe growing?
Placeholder estimate: about 8.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Molecular Diagnostics market report cover?
The report splits the market by technology (PCR, Sequencing, Isothermal Amplification, Microarrays and more), application (Infectious Disease, Oncology, Genetic Disease, Blood Screening) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Molecular Diagnostics market?
Key players include Roche, Abbott Laboratories, Thermo Fisher Scientific Inc., Qiagen N.V., Hologic, Inc. and Danaher Corporation.
What is driving the Molecular Diagnostics market?
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the molecular diagnostics market.
Who regulates Molecular Diagnostics in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Europe

See all

Related on diagnostics and lab testing and genomics

See the topic